To understand how microglial cell function may change with aging, various protocols have been developed to isolate microglia from the young and aged central nervous system (CNS). Here we report modification of an existing protocol that is marked by less debris contamination and improved yields and demonstrate that microglial functions are varied and dependent on age. Specifically, we found that microglia from aged mice constitutively secrete greater amounts of interleukin-6 (IL-6) and tumor necrosis factor-␣ (TNF-␣) relative to microglia from younger mice and are less responsive to stimulation. Also, microglia from aged mice have reduced glutathione levels and internalize less amyloid beta peptide (A␤) while microglia from mice of all ages do not retain the amyloid beta peptide for a significant length of time. These studies offer further support for the idea that microglial cell function changes with aging. They suggest that microglial A␤ phagocytosis results in A␤ redistribution rather than biophysical degradation in vivo and thereby provide mechanistic insight to the lack of amyloid burden elimination by parenchymal microglia in aged adults and those suffering from Alzheimer's disease.
Introduction
A multitude of studies have implicated microglia as important players in the etiology of a number of age-related neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD) and amyotrophic lateral sclerosis (Boillee et al., 2006; Chung et al., 2001; El Khoury et al., 2007; Frautschy et al., 1998; Rogers et al., 2002) . While histological studies are essential in providing clues regarding the cells' involvement, they are limited in terms of evaluating the functions of living cells. In the past decade, protocols to isolate living microglia from postnatal animals have become available (Carson et al., 1998; de Haas et al., 2007; Frank et al., 2006; Hickman et al., 2008; Ponomarev et al., 2005) . These protocols either trap microglia using antibodies to cell-specific antigens (Hickman et al., 2008; Tham et al., 2003) or separate microglia using density centrifugation (de Haas et al., 2007; Frank et al., 2006) . In both cases, the rapid isolation of microglia enables ex vivo experimentation of endogenous microglia in a controlled setting largely devoid of neurons, oligodendrocytes, and astrocytes.
Protocols utilizing density centrifugation are advantageous to those utilizing antigen traps in terms of yield per brain (de Haas et al., 2007) . They also avoid artificial cellular reactions caused by antigen cross-linking, a risk carried with the use of antibodies in trapping protocols. However, in our hands, significant amounts of nonmicro-glial debris contaminate current density centrifugation-derived cultures. In the present study, we sought to modify density centrifugation methodology to eliminate debris fields present in such cultures. With these modifications, microglial yields were preserved or slightly increased. These improvements allowed us to study microglial function and possible alterations during normal aging.
Methods

Solutions
Dispase II (Roche, Mannheim, Germany) was reconstituted at 2 U/mL in dispase buffer (0.9% 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 50 mM NaCl, pH 7.4) according to the manufacturer's instructions. Percoll (GE Healthcare, St. Giles, UK) was diluted 1:10 with 10 ϫ phosphate-buffered saline (PBS) to create an isotonic solution. One ϫ PBS was added to isotonic Percoll to create working solutions ranging from 75% to 25% Percoll.
Animals
Debris reduction experiments were performed with nontransgenic C57BL/6 mice and mice expressing Green fluorescent protein (GFP) under the fractalkine receptor promoter (Jung et al., 2000) . Experiments were performed using neonatal (Ͻ8 days old), young (1-2 month old) and aged (14 -16 month old) male C57BL/6 mice. The mice were housed at 22°C in a controlled 12-hour light/dark cycle and provided food and water ad libitum. Animals were euthanized by exsanguination using transcardiac perfusion with PBS under deep anesthesia with sodium pentobarbital (50 mg/kg body weight). This method of euthanasia is consistent with the recommendations of the Panel of Euthanasia of the American Veterinary Medical Association. After perfusion, the brain (telencephalon, cerebellum, and midbrain) was rapidly removed.
Reduction of debris produced by brain homogenization
Each brain was washed in cold 1 ϫ PBS, then minced using small scissors. Brain tissue was gently dissociated by immersion into 10 mL (per brain) of dispase II solution (2 U/mL), trypsin solution (0.05%), or by grinding within a tissue homogenizer (Glass Potter, Braun, Melsungen, Germany) . Dissociated brain tissue was placed within a 50 mL conical tube and laid horizontally in an orbital shaker set to shake for 1 hour, at 37°C at 150 rpm. Remnant tissue chunks were further homogenized by rapidly triturating with a 10 mL pipette (BD Biosciences, Boston, MA) with a wide bore to prevent cell shearing. This was carried out with a fully charged pipette aid (Drummond, Broomall, PA). Enzyme activity was halted by diluting the resultant homogenate 1:1 with cold 10% fetal bovine serum (FBS) in 1 ϫ PBS. Meninges and clumped cells were removed with 70 m filtration (BD Biosciences, Boston, MA) to obtain a suspension of single cells.
Preparation of discontinuous Percoll gradients
The homogenate was spun at 1000g for 10 minutes at 4°C. The supernatant was discarded and the pellet of an individual brain was resuspended in 6 mL of 75% isotonic Percoll (high Percoll) (GE Healthcare, Buckinghamshire, U.K). Three mL of this mixture was then aliquoted into a 15 mL polystyrene tube. Five mL of 35% isotonic Percoll (low Percoll) was layered atop the high concentration Percoll at a rate of 150 L/second to create a distinct interface between the Percoll layers. To replicate gradients described in the literature, 25% Percoll was utilized for low Percoll. One ϫ PBS was layered atop the low concentration Percoll. The resultant discontinuous gradient was then allowed to settle on ice for 15 minutes allowing most of the homogenate to naturally rise toward its isopycnic position. The gradient was then centrifuged at 800g for 45 minutes in an HS-4 swinging bucket rotor (Thermo, Fisher Scientific, Waltham, MA) set to 4°C. We did not notice changes in microglial yields with high acceleration or the application of the brake. However, yields were significantly diminished if the gradients are not processed immediately following centrifugation. To process the gradients, the volume of the PBS layer and the low concentration Percoll layer were rapidly aspirated. A band of microglia (usually 0.5-1.5 mL), captured between the low concentration and high concentration Percoll layers was then collected and diluted in 50 mL of 1 ϫ PBS. This was centrifuged at 1000g for 10 minutes at full acceleration and brake. The supernatant was quickly decanted and the cell pellet resuspended in Dulbecco's Modified Eagle's Medium (DMEM) culture media containing 10% FBS. We also added 0.15 g/mL granulocyte monocyte colony stimulating factor (GM-CSF, R & D Systems, Minneapolis, MN), although this is not required for culturing microglia.
Immunochemistry
Isolated cells were grown in culture media overnight. Cells were then washed, fixed in 4% paraformaldehyde and processed for immunofluorescence of microglial antigen Iba1 (1: 500, Wako, Richmond, VA), microglial antigen Cd11b (1: 1000, Serotec, Raleigh, NC), astrocyte antigen GFAP (1:1000, Dako Corporation, Carpinteria, CA), and neuronal antigen NeuN (1:500, Millipore, Bellirica, MA). Cells were rinsed and incubated with goat anti-rabbit Alexa 488 (Invitrogen, Carlsbard, CA) and goat anti-mouse Alexa 568 (Invitrogen, Carlsbard, CA). For dendritic cell control experiments, cells were fixed in acetone and blocked for endogenous avidin/ biotin (Vector, Burlingame, CA) and stained with dendritic cell antigen Cd11c (Pharmingen, San Diego, CA) and biotin mouse anti-hamster (Pharmingen, San Diego, CA). Normal mouse spleen sections were utilized as a positive control. Cells were photographed with an Olympus DP71 camera 195.e2 eMalick G. Njie et al. / Neurobiology of Aging 33 (2012) 195.e1-195.e12 (Center Valley, PA) mounted on an Olympus BX60 microscope.
Cell viability
Microglial mitochondrial respiratory activity, a measure of cell viability, was determined using a colorimetric methylthiazolyldiphenyl-tetrazolium bromide (MTT) assay (Bioassay Systems, Hayward, CA). This was compared with a reference value of HEK-293 cells, a highly viable immortal cell line, and dying cultures treated with 1% Triton X-100, a toxic reagent.
Microglial stimulation
In order to compare the inflammatory reaction of microglia in young and aged brains, cells were isolated from 2-and 14-month-old mice, as described above, and seeded in 96-well tissue culture plates (Corning Incorporated, Corning, NY) at a density of 3 ϫ 10 5 cells/well. The cultures were incubated overnight at 37°C with 5% CO 2 and saturated humidity. The next day, cells were stimulated by replacing the original culture media with media containing 2% FBS and immunostimulatory agents in different concentrations. Two highly potent immune stimuli were selected, i.e., lipopolysaccharide (LPS, Escherichia coli 055: B5; Sigma, St. Louis, MO), a toll-like receptor 4 (TLR4) agonist and PamCSK3 (Invitrogen, Carlsbard, CA), a TLR2 agonist. LPS and PamCSK3 were added at a concentration of 10 -100 ng/mL (LPS) or 0.1-1 g/mL (PamCSK3). Control conditions were included, containing no stimuli. After 24 hours of incubation, the media of stimulated microglia were collected and centrifuged for 10 minutes at 20°C and 1200 rpm. The supernatants were used for interleukin-6 (IL-6) and tumor necrosis factor-␣ (TNF-␣) for enzymelinked immunosorbent assay (ELISA). For every condition, cytokine levels were calculated in 3 different wells, while each experiment was performed in quadruplicate.
IL-6 ELISA
Mouse IL-6 secreted protein levels were determined with a general sandwich ELISA protocol. Briefly, an enhanced protein binding ELISA plate (Nunc, Rochester, NY) was incubated overnight at 4°C with the capture antibody, rat anti-mouse IL-6 (BD Bioscience Erembodegem, Belgium). After blocking the nonspecific binding for 2 hours, standards (BD Bioscience Erembodegem, Belgium) and samples were added for 2 hours at room temperature. Subsequently, biotinylated rat anti-mouse IL-6 (BD Bioscience, Erembodegem, Belgium) was used as a detection antibody. Following incubation with a Streptavidin-Horseradish Peroxidase conjugate (Dako Cytomation, Heverlee, Belgium), a TMB substrate (BD BioScience Erembodegem, Belgium) was applied to the plate. Finally, optical densities (OD) were read between 450 and 570 nm, using a Powerwave X Select spectrophotometer (Biotek, Winooski, VT) and concentrations were calculated. The detection limit of the assay was 10 pg/mL.
TNF-␣ ELISA
Mouse TNF-␣ secreted protein levels were measured using a commercially available ELISA kit (eBioscience, San Diego, CA), according to the manufacturer's instructions. Concentrations were determined according to the optical density values, measured using a spectrophotometer (Powerwave X Select) at a wavelength between 450 and 570 nm. The detection limit of the assay was 8 pg/mL.
Glutathione measurements
Total glutathione (reduced and oxidized) was measured in microglia using a glutathione reductase enzymatic recycling assay (Cayman Chemical, Ann Arbor, MI) that is based on the colorimetric conversion of nitrobenzoic acid to 5-thio-2-nitrobenzoic acid (Tietze, 1969) . Briefly, microglia from the brains of young or aged mice were lysed immediately following isolation and prepared for glutathione measurements according to the manufacturer's instructions. Glutathione levels within the range of standards were attained by combining microglia from 4 brains. Therefore to attain 3 repetitions, 12 mice per age group were assayed. All samples were normalized to total protein using bicinchoninic acid (BCA) colorimetric assay (Pierce, Rockford, IL).
A␤42 fate analysis
Amyloid beta peptide (A␤)42 lyophilized protein with and without an fluorescein isothiocyanate (FITC) conjugate (rPeptide, Bogard, GA) was resuspended to 1 mg/mL in 1% NH 4 OH and stored at Ϫ20°C according to the manufacturer's directions. To visualize internalized amyloid beta in living cells, A␤42-FITC was diluted to 4 g/mL in DMEM and added to microglia for 3 hours. The cells were then stained with 4=,6-diamidino-2-phenylindole (DAPI) nuclear counterstain (1:1000) for 5 minutes and imaged. For enhanced subcellular resolution of internalized amyloid beta, cells (exposed to nonconjugated A␤42) were fixed as described above for immunocytochemistry using antibodies against amyloid beta (6E10, 1:2000, Signet Laboratories, Dedham, MA) and the lysosome associated protein, Lamp 1 (1:2, gift from Dr. Notterpek, University of Florida). To determine the aggregation state of A␤42 in stock solutions used in internalization and fate experiments, samples were diluted in Laemmli sample buffer containing 2% sodium dodecyl sulfate (SDS) and loaded in 4%-20% tris glycine-SDS gels (Invitrogen, Carlsbad, CA) for standard SDS polyacrylamide gel electrophoresis. Immunoblots were probed with 6E10 at a dilution of 1:5000. 6E10 has affinity to individual A␤42 peptides and therefore monomers, oligomers, and higher order multimers of A␤42 are distinguishable by size difference. Gel blots were photographed using a Fugi imaging system (Fugifilm Life Science, Stamford, CT).
RS chambers (Nunc, Roskilde, Denmark) that contain a hybrid of glass and polystyrene surfaces have reduced nonspecific interaction with A␤ and were therefore chosen for fate analysis experimentation. To further reduce nonspecific A␤42 absorption, these chambers were blocked with 10% milk for 1 hour. Microglial cells were then isolated from 1-month-old mice, and 15-month-old mice, and mixed glial cultures (MGC) were seeded on RS chambers at approximately 3 ϫ 10 5 cells/chamber. The cultures were incubated overnight at 37°C with 5% CO 2 and saturated humidity. The next day, cultures were rinsed and exposed to A␤42 diluted in DMEM with 10% FBS at 4 g/mL. The cells were allowed to internalize A␤42 from the media for 3 hours in 37°C (1.5 mL/well). They were rinsed and incubated at 37°C with 1.5mL of culture media lacking A␤42. This media and that of cells lysed immediately following rinsing were collected, as were the conditioned media and lysate from wells incubated for 3 and 16 hours. The lysis buffer (1.5 mL/well) consisted of NP-40 (Invitrogen, Carlsbard, CA) supplemented with protease inhibitor cocktail (1ϫ, Sigma, St. Louis, MO) and phenylmethanesulfonyl fluoride (PMSF) (1 mM). For each age group, lysate and media representing 5-7 adult mice or 14 neonatal pups (2 MGCs) were collected. To determine the fate of A␤42, we employed a sandwich-style ELISA (Invitrogen, Carlsbard, CA), configured with 2 capture antibodies (recognizing epitopes on the N terminus and C terminus of human A␤42) to first capture the N terminus of A␤42 and then the C terminus (Schmidt et al., 2005) . Microglial degradative activity on A␤42 causes N-terminal truncations (Majumdar et al., 2007) , thus ELISA reactivity is limited to nondegraded A␤42. We were therefore able to follow: (1) the loss of A␤42; and (2) the expulsion of A␤42 from microglia. The ELISA was processed with duplicates of each sample and absorbance read at 450 nm using a spectrophotometer (Bio-Tek, Winooski, VT). The detection limit of the assay was 10 pg/mL.
Statistical analysis
Average cytokine data are presented as mean Ϯ standard error of the mean (SEM). Statistical analysis was carried out using SPSS version 14.0 for Windows (SPSS, Chicago, IL) . To analyze differences between groups, we used unpaired, 2-tailed Student t test or analysis of variance (ANOVA) with a posthoc Bonferroni test when appropriate. Average A␤ data are presented as mean Ϯ standard error of the mean. For statistical comparison of A␤ internalization between age groups, we used unpaired, 2-tailed Student t test. For statistical comparison of A␤ fate, paired, 2-tailed Student t test was used to compare A␤ levels immediately following internalization and 16 hours later. Data were normalized to mock-treated wells that were treated as described above but contained no cells. For comparison to mock-treated wells, raw data were used. A p-value of Ͻ 0.05 was considered statistically significant.
Results
As reported previously (de Haas et al., 2007; Frank et al., 2006) , centrifugation of dissociated whole brain within discontinuous Percoll gradients can separate microglia from other brain cells. In our hands, the techniques described in the literature yielded insufficiently pure cultures for the pulse-chase experiments we performed (Fig. 1B and C) . Specifically, we observed debris fields which limited the adherence of microglia and may contain components that possibly sequester amyloid beta peptide (Li et al., 2005) . To address this, we utilized dispase II, an enzyme that has been described as particularly gentle, yet capable of tissue dissociation (Borchelt et al., 1992; Gao et al., 2004; McDermott et al., 2003) . Furthermore, we increased the density of Percoll by 16% from that described in the literature (de Haas et al., 2007) . We observed that brains treated with this methodology: (1) had greater separation of dissociated microglia from tissue chunks ( Fig. 1A and B) ; (2) yielded numerous adherent microglia; and (3) were largely devoid of debris (Fig 1C and D) .
Altogether, the combination of these techniques resulted in the extraction of up to 3 ϫ 10 6 microglia per brain. On average, 8.5 ϫ 10 5 microglia per brain were extracted from young and aged mice (Fig. 2B) . Ninety-four percent of cells identifiable by DAPI nuclear stain were reactive to Iba1 (Fig  2A) as determined by 3 observers. The cells had a characteristic amoeboid, phase bright morphology similar to previous reports of adult microglia (Tham et al., 2003) . To further confirm that our isolated cells were indeed microglia, we isolated cells from transgenic mice where GFP expression is under the fractalkine receptor promoter. These mice are reported to have microglia as the only brain cell type to express GFP (Jung et al., 2000) . Upon isolation of cells, our cultures were reactive to antibodies specific to GFP ( Supplementary  Fig. S3A ). Ex vivo cultures of adult microglia that were allowed to adhere overnight were comparable to the HEK 293 cell line in viability (Fig. 2C) . Recent studies have raised the possibility that GM-CSF could push cultured microglia toward a dendritic cell fate (Esen and Kielian, 2007) . In our cultures, microglia grown in 0.15g/mL GM-CSF or in GM-CSF-free conditions both maintained a rounded morphology (Supplementary Fig. S4A ) and had no immunoreactivity to the dendritic cell antigen, Cd11c ( Supplementary Fig. S4B and C) . Interestingly, neonatal microglia derived from mixed glial cultures lacking GM-CSF exhibited a ramified phenotype when cultured overnight in GM-CSF containing media (Supplemetary Fig. 2 ). This morphology is similar to that observed in mixed glial cultures with prolonged exposure to GM-CSF (Esen and Kielian, 2007) . It is possible that the conditions within mixed glial cultures prime microglia to adopt a dendritic-like morphological phenotype upon exposure to GM-CSF.
Previously, histological findings of dystrophic microglia in the aged and diseased brain have led our laboratory to suggest that microglial function may deteriorate with nor-mal aging (Streit et al., 2008) . Therefore, we sought to study elements of pathology that are mainly conferred by microglia in vivo and are known to change with aging and disease (Bolmont et al., 2008; El Khoury et al., 2007; MeyerLuehmann et al., 2008; Streit et al., 2004; Ye and Johnson, 1999) . Recent studies have shown that messenger RNA (mRNA) copies of inflammatory cytokines are increased in microglia from aged brains (Sierra et al., 2007; Ye and Johnson, 1999) . However, mRNA transcripts may not necessarily translate to secreted protein levels (Munger et al., 1995; Storm van's Gravesande et al., 2002) , a more ultimate measure of functional change. To determine if microglia vary their secretion of cytokines with age, we obtained microglia from young and aged mice and measured their cytokine levels with and without exogenous immune stimulation.
The most striking observation in this respect was the dramatic increase in IL-6 release under basal conditions (young: 211.8 Ϯ 31.7 pg/mL vs. aged: 3735.9 Ϯ 1000.2 pg/mL, p Ͻ 0.001). In both young and aged microglia, a significant dose-effect relation following either LPS or Fig. 1 . Dispase II density centrifugation methodology. (A) Brain hemispheres that were homogenized with dispase II and loaded onto discontinuous gradients composed of 35% "low" Percoll and 75% "high" Percoll sequestered microglia to an isopynic density of 1.077 mg/L as determined by beads with known densities. This configuration spatially separated unwanted brain matter to a density 50 g/L more buoyant. (B) Density centrifugation methodology as described in the literature involved mechanical homogenization and reduced Percoll densities. In our hands, such methodology failed to channel unwanted brain matter (tissue chunks, red arrowhead) to an isopynic position distal to the microglia enriched band. (C) Phase-contrast images of freshly prepared cells under a hemacytometer demonstrate reduced particulate matter from dispase II homogenized brains and viable phase-bright cells that exclude trypan blue. Following 24 hours of culture, these cells remain adherent after multiple washes (D) and are thus compatible with experiments that involve media exchanges.
PamCSK3 stimulation was observed ( Supplementary Fig.  S5A ). Moreover, maximal release of IL-6 was significantly enhanced in aged microglial cells following LPS (100 ng/ mL) or PamCSK3 (1 g/mL) stimulation (Fig. 3A) . As with IL-6, the amount of TNF-␣ produced by aged microglial cells was significantly higher under basal conditions when compared with young microglia. While microglia derived from young mice produced no TNF-␣ under basal conditions, the amount was significantly increased to 917.2 Ϯ 91.9 pg/mL in supernatants of aged microglia cultured for 24 hours without any exogenous stimuli (p Ͻ 0.001). This striking difference confirms age-related higher basal levels of cytokine production previously observed with mRNA transcript analysis (Sierra et al., 2007) and shows that aged microglia produce more TNF-␣ than microglia from young mice. This high release under basal conditions may explain the lack of a significant dose-effect relation in TNF-␣ production following either LPS or PamCSK3 stimulation ( Supplementary Fig. S5B ). In contrast, in young microglia a significant dose-effect relation was observed. Moreover, although the maximal amount of TNF-␣ released by aged microglia in response to 1 g/mL PamCSK3 was slightly though significantly increased, responses to 100 ng/mL LPS were not different between aged or young microglia (Fig. 3B) .
In addition to quantifying microglial cytokine production as a function of age, we were interested in whether the ability of microglia to serve as an oxidative sink and to internalize amyloid beta changes with age. Glutathione acts as an antioxidant by neutralizing free radicals and peroxides and microglia are reported to be the primary glutathionecontaining cells in the brain (Hirrlinger et al., 2000; Lindenau et al., 1998) . We found a trend indicating that microglia in aged brains have 21% less total glutathione (oxidized and reduced) compared with microglia from young brains (Supplementary Fig. S6 ). This result suggests that the reactive oxygen species (ROS) insult that can be caused by amyloid beta internalization (Milton et al., 2008) , may be more injurious to microglia in aged brains.
Amyloid beta accumulation is a well recognized feature of AD, however, extensive amyloid deposits may be found in many aged, nondemented individuals (Bouras et al., 1994) . This pathology may result from AD-independent deterioration of clearance processes. Microglial scavenger activity on amyloid beta is proposed as a clearance process that contributes in maintaining amyloid beta at physiological levels by counterbalancing constitutive amyloid beta secretion by neurons. Our laboratory and others have published accounts of microglial degeneration associated with aging (Flanary et al., 2007; Simmons et al., 2007; Streit et al., 2004 Streit et al., , 2008 . If microglia represent a major amyloid beta clearance mechanism, their degeneration would result in progressively increasing amyloid beta levels with age and therefore would have significant implications to the occurrence of amyloidosis in AD and some aged individuals. We currently lack the means to isolate degenerating microglia for experimentation. However, ex vivo assessment of microglia isolated acutely from young and aged mice likely emulates in vivo processing of amyloid beta more so than neonatal or "microglial-like" cell lines and may give insight to the degeneration of microglia with age. Ex vivo cultures of microglia were given media with 4 g/mL of A␤42-FITC conjugate or nonconjugated A␤42. Western blot analysis indicated that nonconjugated A␤42 preparations contained A␤42 monomers, oligomers, and SDS resistant species larger than 220 kDa that are likely fibrils thus reflecting in vivo amyloid burden (Fig. 4A) . Internalization of A␤42 by living microglia was confirmed visually with cell-associated FITC fluorescence (Fig. 4B) . A␤42 observed in fixed cells was colocalized with lysosomes (Fig. 4C) .
To quantify internalization, microglial lysates were measured using an A␤42 sensitive ELISA. Our results indicate that microglia from aged (15-month-old) mice internalize 0.279 ng/mL of A␤42 (Fig. 5A) . In similar experiments recently performed by Zaghi et al., monocytes from aged humans (mean age: 77 years) are reported to internalize 0.256 ng/mL of A␤42, a value within 8% of our findings in aged mouse microglia (Zaghi et al., 2009) . Because circulating monocytes are under certain conditions able to infiltrate the parenchyma, differentiate into microglia (Mildner et al., 2007; Simard and Rivest, 2004) , and modify amyloidosis (Simard et al., 2006) , the similarity of our measurements to human monocyte measurements indicates a strong possibility that our experiments model human physiology.
To determine whether A␤42 processing by microglia from younger mice is reflective of microglia from aged mice, we next performed experiments with microglia from neonates (Ͻ 8 days old, mixed glial culture derived) and young (1-month-old) mice ( Supplementary Fig. S1 ). We found that young microglia internalized 53% more A␤42 relative to aged microglia, while neonatal microglia internalized 45% more A␤42 than young microglia (Fig. 5A) . Neonatal microglia internalized 74% more A␤42 than aged microglia. This suggests that the neonatal microglia commonly used for research on Alzheimer's disease and aging, may not necessarily model adult microglial A␤42 clearance activity.
Internalization of A␤42 is a prerequisite step for intracellular clearance; however it is by no means a surrogate marker for biophysical A␤42 degradation. To more comprehensively determine the fate of phagocytosed A␤42, we bathed cells in fresh media and measured the levels of A␤42 in this media and within cells over 16 hours. We observed that internalized A␤42 is invariably expelled by younger microglial cells within 3 hours (Fig. 5B) . The amount of A␤42 that was expelled by neonatal microglia stayed nearly constant after 3 hours and averages to 18% less than what was originally internalized. This result may mean neonatal microglia were able to degrade some internalized A␤42. Young microglia appeared to continuously expel A␤42 (41% increase between 3 and 16 hours). At 16 hours, young microglia expelled 27% more A␤42 than neonatal microglia. We did not see significant evidence of A␤42 expulsion by aged microglia though these microglia have reduced amounts of internalized A␤42 over time. The amount of A␤42 internalized by aged microglia is not significantly different from mock experiments. Therefore, we were unable to assess whether these cells have degradation capacities.
Interestingly, the amount of A␤42 expelled by young microglia at 3 and 16 hours was 19% and 53% more than was initially internalized. In mock measurements performed alongside neonatal and young microglial experiments, we found that A␤42 capture is enhanced by 31% in the media compared with lysis buffer. Lysates are composed of a Fig. 3 . Cytokine secretion of young and aged microglia. (A) Upon stimulation with the biological immunostimulatory agent lipopolysaccharide (LPS) (100 ng/mL), or Pam3CSK4, a synthetic agonist of toll-like receptor 2 (1 g/mL), interleukin-6 (IL-6) production by aged microglia was markedly increased when compared with young microglia. (B) LPS (100 ng/ mL) stimulated similar tumor necrosis factor-␣ (TNF-␣) production in microglia derived from young and aged mice. Yet, TNF-␣ production was significantly increased in aged microglia following Pam3CSK4 (1 g/mL) exposure. *, p Ͻ 0.05; #, p Ͻ 0.001. complex mixture that includes chemicals for lysis, protease inhibitors, cell-derived proteins, as well as lipids. These are not found in the media. Because a more limited set of soluble proteins compete for ELISA antibody binding in the media, one would expect enhanced capture of A␤42 in this environment. Consequently, our assay does not yield stoichiometric data needed for affirmative determination of A␤42 degradation. However our assay clearly detects significant increases in conditioned media A␤42 content suggesting substantial movement of A␤42 to the outside of cells following initial internalization. This effect is agerelated as it is only observed in younger microglial cells.
Discussion
In this report, we aimed to reduce debris contamination which is a feature of microglial cultures derived from gradient centrifugation-based methodology. The brains of mice that are designated by the National Institute on Aging as an aging model were treated successively to steps that significantly increased the purity of ex vivo microglial cultures. Analysis of such cultures, derived from mice of various aging categories, revealed that microglia from aged brains have markedly increased basal levels of IL-6 and TNF-␣ secretion, have reduced glutathione levels and have a limited capacity to ingest A␤42. In contrast, microglia from younger mice are able to temporarily contain A␤42. Together, these ex vivo findings provide evidence that microglia are subject to age-associated changes in biology.
Prior reports from our laboratory have shown that microglia have IL-6 and TNF-␣ mRNA (Streit et al., 2000) and more recently, others have found age-related changes in microglial IL-6 and TNF-␣ mRNA (Sierra et al., 2007) . We extend on these results by measuring secreted IL-6 and TNF-␣ proteins. Our results indicate significantly more pronounced changes in basal cytokine production and responsiveness. It is difficult to make direct comparisons of mRNA and secreted protein measurements. However, it is of note that the margin of change we observe in the basal production of IL-6 between microglia from young and aged mice is approximately 4-fold higher than that observed by mRNA analysis (⌬17.6ϫ vs. ⌬5ϫ respectively). We also did not observe detectable levels of basal TNF-␣ by microglia from young animals in our studies. These differences can perhaps be explained by varying sensitivities of the employed detection methodologies or by posttranscriptional effects. The half-life of mRNA can often be rate-limiting in translation (Ross, 1995) . Secondarily, secretory pathway modulation of newly produced cytokines may also modulate the concentration of cytokines in the extracellular milieu independent of DNA transcription. As microRNAs are involved in regulation of gene expression at the posttranscriptional level, possible changes in this machinery can also be mentioned to explain the discrepancy between protein and mRNA levels. Our results, though in agreement with previous reports, indicate that microglia from brains of various aging groups have much greater differences in cytokine production, and , and higher-order conformations larger than 220 kDa in stock preparations as well as preparations that have been exposed to microglia. Higher-order conformations larger than 220 kDa persist following the exposure of samples to buffer containing 2% sodium dodecyl sulfate (SDS) suggesting the presence of fibrillar species. Ten percent serum in media overloads gel at 60 kDa and may block visibility of some A␤42 species (75 ng of A␤42/well). (B) Internalization of A␤42 by microglia from adult mice was directly observed in living microglia with FITC-conjugated A␤42 peptide and with 6E10 immunocytochemistry. In both cases, A␤42 had a perinuclear localization. Lamp1 colocalization with 6E10 immunoreactivity suggests that some A␤42 reached microglial lysosomal compartments (C).
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What are the possible implications of age-related changes in microglial cytokine production? A number of authors commonly describe IL-6 and TNF-␣ as neurotoxic molecules involved in AD pathogenesis (Bruunsgaard et al., 1999; Collins et al., 2000; Culpan et al., 2003; He et al., 2002 , Li, et al., 2007 , Licastro et al., 2000 McGeer and McGeer, 2001) . However, experiments presenting alternative viewpoints have been published (Brunello et al., 2000; Loddick et al., 1998; Marz et al., 1998; Streit et al., 2000; Tarkowski et al., 1999; Thier et al., 1999; Wei et al., 1992) . IL-6 may have a role in regeneration of injured tissue in the brain (Loddick et al., 1998; Streit et al., 2000; Tarkowski et al., 1999) , has known antiapoptotic properties (Wei et al., 2001) and in mice that overexpress both IL-6 and its receptor, IL-6R␣, there is no evidence of neurotoxicity (Brunello et al., 2000) . Inflammation is a component of the healing process of acute central nervous system (CNS) lesions (Klein et al., 1997; Streit et al., 2000) . Recently, it has been reported that the more chronic lesions of tauopathy and amyloidosis can be found in 20%-40% of nondiseased, aged adults at levels comparable to AD patients (Price et al., 2009) . Both TNF-␣ and IL-6 increase with aging (Bruunsgaard et al., 1999; Wei et al., 1992) . Thus, the aging brain appears to exist in a constant state of injury. Inflammatory processes, such as microglial secretion of IL-6, may be needed for persistent regeneration or neuroprotection. The viewpoints that cytokine release is exclusively neurotoxic or neuroprotective could be equally considered speculative. Further studies which consider region-specific and age-specific differences in cytokine response are needed, amongst others, to shed light onto the role of cytokines released by microglia on the nervous system.
Microglial surveillance of the parenchyma involves scavenging of potentially hazardous materials. Proteins such as LPS and A␤ induce ROS and it is thought that the increased levels of antioxidant molecules such as glutathione found in microglia relative to other brain cells (Hirrlinger et al., 2000; Lindenau et al., 1998) protect microglia from ROS burden associated with scavenging activity (Dringen, 2005; Milton et al., 2008; Qin et al., 2004; Tchaikovskaya et al., 2005) . Our findings of reduced glutathione levels in microglia immediately analyzed after brain extraction may be indicative of broader microglial loss of function with age.
Our overall conclusion of age-related changes in microglial processing of A␤ is indirectly supported by published work demonstrating decreased protein turnover in adult rat microglia (Stolzing et al., 2006) . More recently, experiments by Zahgi et al. show monocytes from aged humans internalized A␤42 at amounts comparable to what we observe in aged mouse microglia (Zaghi et al., 2009 ). Similar to our findings, the A␤ internalized by monocytes was not detected in cell lysates within hours. In other work, media were measured for radiolabeled soluble A␤ previously internalized by neonatal microglia. These investigators concluded that most A␤ is expelled in an interval of time similar to our findings (Chung et al., 1999) . Together, these data provide independent support for the amount of A␤ we measure in lysates, the kinetics of A␤ movement, and our conclusion that the principal consequence of A␤ internalization by younger microglia is expulsion.
Microglia are thought to participate in plaque burden regulation by sequestering and processing of A␤. Our purpose in performing A␤ metabolism experiments with ex vivo cultures of microglia was to further understand the relationship between microglia and A␤42 homeostasis. Individual microglia surrounding A␤ plaques become enlarged as plaques become smaller with time (Bolmont et al., 2008) . Despite this correlative evidence of microglial par- Microglia extracted from mice of various ages were exposed to A␤42 preparations containing monomeric, oligomeric, and sodium dodecyl sulfate (SDS)-resistant fibrillar species (reflecting in vivo amyloid diversity) in pulse-chase experiments. (A) Neonatal and young microglia respectively internalized 74% and 53% more A␤42 relative to aged microglia. (B) Invariably, internalized A␤42 was expelled by neonatal and young microglia within 3 hours of ingestion, suggesting disengagement from biophysical degradation following phagocytosis. Mock data (light gray) represents experiments without the presence of cells to control for nonspecific adherence of A␤ to culture wells. Detection of A␤42 requires the presence of both NH 2 and COOH terminals of A␤42, thus only intact A␤42 peptides are quantified in the above experiments. *, p Ͻ 0.05; **, p Ͻ 0.01. ticipation in A␤ plaque reduction, natural processes do not appear to reverse amyloidosis (Jankowsky et al., 2005) . Previously, we have suggested that microglial function may deteriorate with time. This was mainly inspired by histological findings, demonstrating the appearance of a dystrophic microglia phenotype with normal aging and around neuritic plaques in AD brains (Streit et al., 2009) . The finding that microglia from young brains internalize more A␤42 than microglia from aged brains likely reflects a more global change in microglial functionality with aging.
In younger mice, the temporary sequestration of A␤42 suggests that microglia are not directly involved in significant amounts of degradation. However there is clear potential for microglia, which are highly motile (Bolmont et al., 2008) , to be involved in the movement of A␤ in the nervous system. The cycling of A␤42 through microglial endocytosis and exocytosis could result in redistribution that modulates peptide availability for amyloid formation. Our observations indicate that microglia remove A␤ peptide out of the extracellular milieu at ng/mL quantities, possibly creating a dynamic cellular compartment in vivo. A 2-to 4-fold agerelated decrease in microglial A␤ internalization as observed in our experiments could result in less transfer of A␤ from the extracellular space, thereby making available more A␤ for plaque formation. It is plausible that the dynamic redistribution of A␤, a protein that is particularly aggregation prone, is needed for homeostatic maintenance. Perturbation of this process due to age-related changes of microglial function such as that described here could contribute to unhinged accumulation of A␤ to toxic concentrations in the extracellular space. In 3-month-old mice where in vivo microglia were selectively killed, soluble A␤40 and A␤42 levels increase by 3-to 4-fold (Grathwohl et al., 2009 ). This suggests that the presence of microglia is needed to prevent the accumulation of soluble pools of A␤ in young mice. Such pools contain the building blocks of A␤ pathology according to the amyloid cascade theory (Tanzi and Bertram, 2005) . Interestingly, amyloidosis has recently been described to occur in up to 40% of nondemented, aged adults (Price et al., 2009) . It is possible that changes in microglial processing of A␤ may contribute to occurrences of amyloidosis in the aged population. Suggestive evidence for this comes from studies of monocytes. In these studies, monocytes from Alzheimer's patients internalize half as much A␤42 as those from aged adults (Zaghi et al., 2009) . Importantly, aged monocytes have a similar capacity to internalize A␤42 as aged mouse microglia measured here. We infer from our data that monocytes and microglia from younger humans will have greater internalization of A␤42. We propose that as microglia and possibly monocytes age, they lose important capacities to internalize and redistribute A␤. A progressive loss of cellular function as described here may be an understudied mechanism that contributes to the development of amyloid pathology in aged, nondemented subjects and in patients with Alzheimer's disease.
Together, our ex vivo quantification of microglial functions of cytokine production, glutathione levels, and A␤42 scavenging activity paint a complex picture of endogenous activity. Microglia from young mice produce less cytokines, while microglia derived from aged mice have higher basal levels of cytokine secretion than was previously thought and have reduced glutathione levels. Microglia derived from aged mice have diminished A␤42 internalization capacity relative to their younger counterparts. However, these younger microglia expel significant amounts of internalized A␤42. These direct assessments of microglial function in ex vivo experiments, free of confounding contributions of other brain cells and debris, demonstrate a nuanced view of microglial function and suggest that microglial biology may change with aging.
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